Infigratinib | CAS 872511-34-7 - Request Quote
Infigratinib
| SZ CAT No: | SZ-I065001 |
| CAS No | 872511-34-7 |
| Mol.F. | C26H31Cl2N7O3 |
| Mol.Wt. | 560.5 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 1310746-15-6 (HCl salt) ; 1310746-11-2 (hydrate salt) ; 1310746-22-5 (HBr salt) |
| Shipping Condition | Room Temperature |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Infigratinib is chemically 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)-1-methylurea. Infigratinib is supplied with detailed characterization data compliant with regulatory guideline. Infigratinib can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Infigratinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 872511-34-7
Purchase 872511-34-7
Order 872511-34-7
Enquire 872511-34-7
price of 872511-34-7
872511-34-7 Supplier
872511-34-7 Manufacturer
872511-34-7 Exporter
buy high quality Infigratinib
Purchase Infigratinib
Infigratinib suppliers
Infigratinib manufacturers
Infigratinib price
Order Infigratinib
Enquire Infigratinib
Infigratinib cost
Infigratinib Supplier
Infigratinib Distributor
Infigratinib for Method Validation
Infigratinib Reference Standard
Infigratinib for ANDA Filing
Infigratinib for Forced Degradation Studies
Infigratinib Identification Standards
Infigratinib for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.